ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.07
0.46%
US Tech 100
17,244.80
1.57%
S&P 500
5,099.96
1.02%
US Dollar vs CAD
1.36805
0.00%
Bitcoin
63,546.28
0.21%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Galera Therapeutics Inc (GRTX)

  7. Galera Therapeutics Inc (GRTX) News

GRTX Galera Therapeutics Inc

0.1879
-0.0196 (-9.45%)
Apr 26 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Galera Therapeutics Inc GRTX NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.0196 -9.45% 0.1879 18:55:58
Open Price Low Price High Price Close Price Previous Close
0.2013 0.1861 0.2165 0.1861 0.2075
more quote information »

Recent News

Date Time Source Heading
3/28/202406:00GLOBEGalera Reports Fourth Quarter and Full Year 2023 Financial..
2/26/202415:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/20/202417:57EDGAR2Form SC 13D/A - General statement of acquisition of..
1/16/202417:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
11/14/202306:00GLOBEGalera Reports Third Quarter 2023 Financial Results and..
11/13/202313:24EDGAR2Form SC 13G - Statement of acquisition of beneficial..
10/31/202307:09DJNGalera Shares Halted After FDA Says Avasopasem Needs..
10/31/202306:10EDGAR2Form 8-K - Current report
10/31/202306:00GLOBEGalera Announces Receipt of Type A Meeting Minutes and..
9/26/202306:24EDGAR2Form 8-K - Current report
9/22/202316:12EDGAR2Form 8-K - Current report
9/18/202306:00GLOBEGalera Schedules Type A Meeting with FDA to Discuss Next..
9/05/202306:00GLOBEGalera to Participate in the H.C. Wainwright 25th Annual..
8/14/202306:30EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
8/14/202306:10EDGAR2Form 8-K - Current report
8/14/202306:00GLOBEGalera Reports Second Quarter 2023 Financial Results and..
8/10/202307:00EDGAR2Form 8-K - Current report
8/09/202319:10DJNStocks to Watch: Applovin, Disney, Galera Therapeutics
8/09/202316:23DJNGalera Therapeutics to Reduce Workforce by 70% to Extend..
8/09/202315:31GLOBEGalera Receives Complete Response Letter from U.S. FDA for..
7/05/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
6/05/202313:15GLOBEGalera Presents Additional Chronic Kidney Disease Data from..
5/18/202307:44DJNGalera Therapeutics Gets Orphan Drug Designation for..
5/18/202307:00GLOBEGalera Announces FDA Orphan Drug Designation Granted to..
5/11/202306:00GLOBEGalera Reports First Quarter 2023 Financial Results and..
5/04/202315:01GLOBEGalera Reports Inducement Grants Under Nasdaq Listing Rule..
5/01/202306:00GLOBEGalera Expands Commercial Leadership Team

Your Recent History

NASDAQ
GRTX
Galera Therapeutics
Delayed Upgrade Clock
ADVFN Logo

Canada
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved